Fobi AI Selected To Represent Canadian AI Tech at Asia Tech X Event in Singapore, May 29-31, 2024, at The Singapore EXPO
May 23, 2024 08:00 ET
|
Fobi AI Inc.
VANCOUVER, BC, May 23, 2024 (GLOBE NEWSWIRE) -- Fobi AI Inc. (FOBI:TSXV) (FOBIF:OTCQB) (the "Company" or "Fobi"), an industry leader in harnessing AI and data intelligence to enable digital...
Ackroo Releases Q1 2024 Financial Results
May 23, 2024 08:00 ET
|
Ackroo Inc.
HAMILTON, Ontario, May 23, 2024 (GLOBE NEWSWIRE) -- Ackroo Inc. (TSX-V: AKR; OTC: AKRFF) (the “Company”), a gift card, loyalty marketing, payments and point-of-sale technology consolidator and...
NowVertical Group Announces First Quarter 2024 Earnings Release Date and Financial Webinar
May 23, 2024 07:30 ET
|
NowVertical Group Inc
TORONTO, May 23, 2024 (GLOBE NEWSWIRE) -- NowVertical Group Inc. (TSX-V: NOW) (OTCQB: NOWVF) (“NOW” or the “Company”), a leading data analytics and AI solutions company, will announce its 2024 first...
Labrador Gold Provides Update on Sale of Kingsway Project
May 23, 2024 07:30 ET
|
Labrador Gold Corp.
TORONTO, May 23, 2024 (GLOBE NEWSWIRE) -- Labrador Gold Corp. (TSX.V:LAB | OTCQX:NKOSF | FNR:2N6) (“LabGold” or the “Company”) is pleased to announce that further to its press release dated April...
Plato Gold Reports on First Quarter Results
May 23, 2024 07:30 ET
|
Plato Gold Corp.
Toronto, ON, May 23, 2024 (GLOBE NEWSWIRE) -- Plato Gold Corp. (TSX-V: PGC) (OTCQB: NIOVF) (Frankfurt: 4Y7 or WKN: A0M2QX) (“Plato” or the “Company”) an exploration company with a portfolio of...
Rakovina Therapeutics Announces $1.5 million Non-Brokered Private Placement
May 23, 2024 07:30 ET
|
Rakovina Therapeutics Inc
All monetary figures listed in Canadian Dollars. VANCOUVER, British Columbia, May 23, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company” or “Rakovina Therapeutics”) a...
ARCPOINT TO HOST CONFERENCE CALL TO DISCUSS 2024 Q1 FINANCIAL RESULTS
May 23, 2024 07:00 ET
|
ARCpoint Inc.
Greenville, South Carolina, May 23, 2024 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the “Company” or “ARCpoint”) a leading US-based franchise system providing drug testing, alcohol screening,...
Hydreight Technologies through its associated Medical network now offer Tirzepatide to Product Offering which also features GLP-1 Medications (Low-Cost Semaglutide), NAD+ and more
May 23, 2024 07:00 ET
|
Hydreight Technologies Inc.
Tirzepatide, a dual GIP and GLP-1 receptor agonist (GIP/GLP-1 RA), is an antidiabetic medication used for the treatment of type 2 diabetes and for weight loss. The GLP-1 segment is an important class...
Leading Proxy Advisory Firm ISS Recommends that Mayfair Gold Shareholders Vote FOR All Company Nominees
May 23, 2024 07:00 ET
|
Mayfair Gold Corp.
ISS concludes that Muddy Waters “has not articulated any credible path forward”Mayfair Board regrets Muddy Waters’ unwillingness to engage constructively MATHESON, Ontario, May 23, 2024 (GLOBE...
Rivalry to Report First Quarter 2024 Results on May 30
May 23, 2024 07:00 ET
|
Rivalry Corp.
Rivalry announces details for its Q1 2024 earnings release and investor conference call planned for May 30, 2024.